Randall N. Hyer, MD, PhD, MPH, former Moderna executive, named president of the Baruch S. Blumberg Institute <<click here>>.

International society elects Blumberg Institute scientist as board secretary

 Doylestown, Pa., Feb. 22, 2022 – Jinhong Chang, MD, PhD, professor at the Baruch S. Blumberg Institute, recently was elected secretary of the International Society for Antiviral Research (ISAR). ISAR is an internationally recognized organization for scientists involved in basic, applied and clinical aspects of antiviral research.

At the Blumberg Institute, Dr. Chang is director, Laboratory of Molecular Virology and Antiviral Research, Department of Experimental Therapeutics. She has more than 20 years of research experience in the areas of molecular virology, innate immunity and antiviral drug discovery, with over 100 publications in the field.

The other newly elected ISAR board members are Luis Schang of Cornell University (ISAR board president), Andrea Brancale of Cardiff University in Wales and Zlatko Janeba of the Institute of Organic Chemistry and Biochemistry in Prague.

The newly elected members will begin their terms next month. There is more information about Dr. Chang here.

About the Baruch S. Blumberg Institute

An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is one of the nation’s leading centers for translational research, particularly for hepatitis B and liver cancer. The Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease and liver cancer in an environment conducive to interaction, collaboration and focus. The Blumberg Institute is located in the Pennsylvania Biotechnology Center, which it manages, near Doylestown, Pa. For more, go to www.blumberginstitute.org and follow us on Twitter @BlumbergInstit1.